In-depth studies of the expression of CPEB1 and COLEC12 in fibroblasts and their roles in immune microenvironment interactions, particularly the complicated mechanisms connecting fibroblasts with immune cells, might provide novel strategies for BC immunotherapies in patients with diabetes. Here, COLEC12 is linked to diabetes mellitus.